Review





Similar Products

flow cytometry staining buffer  (Thermo Fisher)
96
Thermo Fisher flow cytometry staining buffer
Flow Cytometry Staining Buffer, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/flow cytometry staining buffer/product/Thermo Fisher
Average 96 stars, based on 1 article reviews
flow cytometry staining buffer - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
permeabilization buffer set  (Multi Sciences (Lianke) Biotech Co Ltd)
96
Multi Sciences (Lianke) Biotech Co Ltd permeabilization buffer set
Permeabilization Buffer Set, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/permeabilization buffer set/product/Multi Sciences (Lianke) Biotech Co Ltd
Average 96 stars, based on 1 article reviews
permeabilization buffer set - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
facs buffer  (R&D Systems)
96
R&D Systems facs buffer
Facs Buffer, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/facs buffer/product/R&D Systems
Average 96 stars, based on 1 article reviews
facs buffer - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
dna staining solution  (Multi Sciences (Lianke) Biotech Co Ltd)
96
Multi Sciences (Lianke) Biotech Co Ltd dna staining solution
Dna Staining Solution, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dna staining solution/product/Multi Sciences (Lianke) Biotech Co Ltd
Average 96 stars, based on 1 article reviews
dna staining solution - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
pi rnase staining buffer  (Multi Sciences (Lianke) Biotech Co Ltd)
96
Multi Sciences (Lianke) Biotech Co Ltd pi rnase staining buffer
Pi Rnase Staining Buffer, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pi rnase staining buffer/product/Multi Sciences (Lianke) Biotech Co Ltd
Average 96 stars, based on 1 article reviews
pi rnase staining buffer - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
staining buffer  (Multi Sciences (Lianke) Biotech Co Ltd)
96
Multi Sciences (Lianke) Biotech Co Ltd staining buffer
Staining Buffer, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/staining buffer/product/Multi Sciences (Lianke) Biotech Co Ltd
Average 96 stars, based on 1 article reviews
staining buffer - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
1x flow cytometry staining buffer  (R&D Systems)
96
R&D Systems 1x flow cytometry staining buffer
(A) Experimental timeline of T-FUS+αCD40 dosing and harvest for flow <t>cytometry</t> analysis. (B) Average tumor outgrowth of E0771 tumor-bearing mice. Significance assessed by 2-way ANOVA, followed by Holm-Sidak multiple comparison correction. E0771: p<0.05 vs all other groups (specifically, IgG (n=5) vs T-FUS+αCD40 (n=12): p = <0.0001; T-FUS (n=7) vs T-FUS+αCD40: p =0.0843; αCD40 (n=7) vs T-FUS+αCD40: p = 0.0517). (C) Focused view of tumor outgrowth at selected timepoints (day 42-53) highlighting differences between T-FUS+αCD40 non-CRs and CRs, versus αCD40 monotherapy. (D) Waterfall plot depicting CRs in the combination treatment group. (E-H) Absolute number per gram tumor and percentage of CD8 + and CD4 + T cells in the tumor and (I-L) spleen. M) tSNE plot on CD45 + cells in the TDLN. (N-Q) Absolute number and percentage of CD8 + and CD4 + T cells in the TDLN. (R) Ratio between CD8 + and CD4 + T cells in the TDLN. Significance assessed using a Welch ANOVA or Welch’s T test. *p < 0.05, **p < 0.01 vs. T-FUS+αCD40 CRs.
1x Flow Cytometry Staining Buffer, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/1x flow cytometry staining buffer/product/R&D Systems
Average 96 stars, based on 1 article reviews
1x flow cytometry staining buffer - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

Image Search Results


(A) Experimental timeline of T-FUS+αCD40 dosing and harvest for flow cytometry analysis. (B) Average tumor outgrowth of E0771 tumor-bearing mice. Significance assessed by 2-way ANOVA, followed by Holm-Sidak multiple comparison correction. E0771: p<0.05 vs all other groups (specifically, IgG (n=5) vs T-FUS+αCD40 (n=12): p = <0.0001; T-FUS (n=7) vs T-FUS+αCD40: p =0.0843; αCD40 (n=7) vs T-FUS+αCD40: p = 0.0517). (C) Focused view of tumor outgrowth at selected timepoints (day 42-53) highlighting differences between T-FUS+αCD40 non-CRs and CRs, versus αCD40 monotherapy. (D) Waterfall plot depicting CRs in the combination treatment group. (E-H) Absolute number per gram tumor and percentage of CD8 + and CD4 + T cells in the tumor and (I-L) spleen. M) tSNE plot on CD45 + cells in the TDLN. (N-Q) Absolute number and percentage of CD8 + and CD4 + T cells in the TDLN. (R) Ratio between CD8 + and CD4 + T cells in the TDLN. Significance assessed using a Welch ANOVA or Welch’s T test. *p < 0.05, **p < 0.01 vs. T-FUS+αCD40 CRs.

Journal: bioRxiv

Article Title: Focused Ultrasound Thermal Ablation and CD40 Agonism Reprograms Breast Tumor Immunity to Drive Regression and Memory

doi: 10.64898/2026.03.02.708396

Figure Lengend Snippet: (A) Experimental timeline of T-FUS+αCD40 dosing and harvest for flow cytometry analysis. (B) Average tumor outgrowth of E0771 tumor-bearing mice. Significance assessed by 2-way ANOVA, followed by Holm-Sidak multiple comparison correction. E0771: p<0.05 vs all other groups (specifically, IgG (n=5) vs T-FUS+αCD40 (n=12): p = <0.0001; T-FUS (n=7) vs T-FUS+αCD40: p =0.0843; αCD40 (n=7) vs T-FUS+αCD40: p = 0.0517). (C) Focused view of tumor outgrowth at selected timepoints (day 42-53) highlighting differences between T-FUS+αCD40 non-CRs and CRs, versus αCD40 monotherapy. (D) Waterfall plot depicting CRs in the combination treatment group. (E-H) Absolute number per gram tumor and percentage of CD8 + and CD4 + T cells in the tumor and (I-L) spleen. M) tSNE plot on CD45 + cells in the TDLN. (N-Q) Absolute number and percentage of CD8 + and CD4 + T cells in the TDLN. (R) Ratio between CD8 + and CD4 + T cells in the TDLN. Significance assessed using a Welch ANOVA or Welch’s T test. *p < 0.05, **p < 0.01 vs. T-FUS+αCD40 CRs.

Article Snippet: Following, cells were fixed with anti-mouse CD16/32 (ThermoFisher #14-0161-86) to block Fc gamma receptors for 15 mins at 4oC, then centrifuged and washed twice with 1X Flow Cytometry Staining Buffer (FACS; R&D Systems #FC001).

Techniques: Flow Cytometry, Comparison